Alegent Health

Esperion Therapeutics, Inc. is a biopharmaceutical company based in Ann Arbor, MI, that focuses on advancing cardiovascular disease management through innovative treatments and partnerships. The company has two approved therapies in the US and Europe, leveraging a unique mechanism of action to enhance global access to its medications. With a commitment to scientific discovery, Esperion is at the forefront of investigating ACLY biology, having introduced the first ACLY inhibitor to the market. The organization utilizes cutting-edge discovery technology and data science to uncover new therapeutic opportunities and develop next-generation inhibitors targeting life-threatening diseases. Generated from the website